文献速递类风湿关节炎

ACPA阳性与阴性RA在临床关节炎前症状期的差异:一项纵向研究

Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis.
PubMed 文献 · Ann Rheum Dis · 2017-06-12

该研究纳入Leiden临床可疑关节痛队列中随访期间发展为关节炎的67例患者,比较ACPA阳性与阴性患者在症状初发、关节痛就诊时及进展至关节炎的时间差异。结果显示两组在初始症状部位、就诊时症状持续时间和体征及进展速度上存在差异,提示ACPA阳性与阴性RA在临床关节炎前阶段即表现不同。

要点

  • ACPA阴性患者初始症状较少累及下肢(22% vs 50%,p=0.014)。
  • 就诊时ACPA阳性患者症状持续时间更长(中位22 vs 14周,p=0.005),压痛关节数更少(均值5 vs 9,p=0.007)。
  • 就诊后ACPA阳性患者进展至关节炎更快(中位6 vs 18周,p=0.015)。

核心结论

  • ACPA阳性与ACPA阴性患者在临床关节炎前症状期即存在临床差异,支持两型RA发病机制不同。

研究设计与样本

  • 研究纳入Leiden临床可疑关节痛队列中随访期间发展为关节炎的67例患者,比较ACPA阳性与阴性患者的症状特征及进展时间。

主要发现

  • ACPA阴性患者(n=37)初始症状累及下肢的比例为22%,ACPA阳性患者为50%(p=0.014)。
  • 就诊时ACPA阳性患者症状持续时间中位22周,ACPA阴性患者为14周(p=0.005)。
  • 就诊时ACPA阳性患者压痛关节数均值5个,ACPA阴性患者为9个(p=0.007)。
  • 就诊时ACPA阳性患者握拳困难比例为11%,ACPA阴性患者为43%(p=0.004)。
  • 就诊后ACPA阳性患者进展至关节炎的中位时间为6周,ACPA阴性患者为18周(p=0.015)。

关键数值与推荐

  • 偏最小二乘回归分析显示ACPA阳性与阴性患者基于上述临床变量可聚类区分。

临床怎么用

  • 对于临床可疑关节痛患者,ACPA状态有助于预判症状特征及进展至临床关节炎的速度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although anticitrullinated protein antibody (ACPA)-positive and ACPA-negative rheumatoid arthritis (RA) have different aetiopathology, the clinical presentation at the time of diagnosis is similar. This study evaluated whether there are phenotypic differences in the symptomatic pre-RA phase. METHODS: Patients with arthralgia included in the Leiden clinically suspect arthralgia cohort who developed arthritis during follow-up were studied (n=67). Symptoms at symptom onset, symptoms and signs at presentation with arthralgia and time to arthritis development were compared between ACPA-positive and ACPA-negative patients. RESULTS: In ACPA-negative patients (n=37), the location of initial symptoms less often included the lower extremities (22% vs 50%, p=0.014). At presentation with arthralgia, ACPA-positive patients had a longer symptom duration (median 22 vs 14 weeks, p=0.005), less tender joints (mean 5 vs 9, p=0.007) and less difficulty making a fist (11% vs 43%, p=0.004). However, after presentation with arthralgia, ACPA-positive patients developed arthritis more quickly (median 6 vs 18 weeks, p=0.015). A partial least squares regression analysis showed clustering of ACPA-positive and ACPA-negative patients based on the above-mentioned clinical variables. CONCLUSION: This study is the first showing that ACPA-positive and ACPA-negative patients have clinical differences in the symptomatic phase preceding clinical arthritis. This contributes to the notion that ACPA-positive and ACPA-negative RA develop differently.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Burgers LE, van Steenbergen HW, Ten Brinck RM, et al. Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis. Ann Rheum Dis. 2017. PMID: 28606964. doi:10.1136/annrheumdis-2017-211325

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。